Veeva Systems/$VEEV

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Veeva Systems

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Ticker

$VEEV

Primary listing

NYSE

Industry

Health Care Technology

Employees

7,291

ISIN

US9224751084

Veeva Systems Metrics

BasicAdvanced
$46B
59.93
$4.71
0.99
-

What the Analysts think about Veeva Systems

Analyst ratings (Buy, Hold, Sell) for Veeva Systems stock.

Bulls say / Bears say

Veeva Systems reported a 14.3% year-over-year increase in revenue for Q4 FY2025, reaching $720.89 million, with subscription services revenue climbing 17% to $608.6 million, indicating strong demand for its cloud-based solutions. (fool.com)
The company announced the inclusion of Direct Data API in its Veeva Vault Platform at no additional cost, enhancing data accessibility and potentially driving AI innovation in the life sciences sector. (nasdaq.com)
Veeva Systems' stock reached a 52-week high of $286.99, reflecting a 59.15% one-year return, underscoring strong investor confidence and market optimism about its growth prospects. (investing.com)
Despite announcing the inclusion of Direct Data API to enhance AI capabilities, Veeva's stock declined by nearly 3.6% following the news, suggesting potential investor concerns about the immediate impact of this initiative. (nasdaq.com)
The decision to end its partnership with Salesforce in September 2025 and migrate Veeva CRM onto its own Vault Platform introduces execution risks and potential client disruptions during the transition. (wikipedia.org)
Insider selling activity, such as SVP Jonathan Faddis selling 1,694 shares and insider Thomas D. Schwenger selling 1,126 shares, may raise concerns about internal confidence in the company's future performance. (tickerreport.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.

Veeva Systems Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Veeva Systems Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VEEV

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs